Page 2 - குரா புற்றுநோயியல் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from குரா புற்றுநோயியல் இன்க். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In குரா புற்றுநோயியல் இன்க் Today - Breaking & Trending Today

Kura Oncology Announces Clinical Collaboration to Evaluate Tipifarnib in Combination with Alpelisib in Head and Neck Squamous Cell Carcinoma

Kura Oncology Announces Clinical Collaboration to Evaluate Tipifarnib in Combination with Alpelisib in Head and Neck Squamous Cell Carcinoma
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Roberth Uhl , Stephen Dale , Exchange Commission , Corporate Communications , Kura Oncology Inc , Canale Communications , Kura Oncology , Chief Medical Officer , Cancer Genome Atlas , Breakthrough Therapy , Fast Track Designations , Breakthrough Therapy Designation , Investor Relations , ஸ்டீபன் டேல் , பரிமாற்றம் தரகு , பெருநிறுவன தகவல்தொடர்புகள் , குரா புற்றுநோயியல் இன்க் , கால்வாய் தகவல்தொடர்புகள் , குரா புற்றுநோயியல் , தலைமை மருத்துவ அதிகாரி , புற்றுநோய் மரபணு அட்லஸ் , திருப்புமுனை சிகிச்சை , திருப்புமுனை சிகிச்சை பதவி , முதலீட்டாளர் உறவுகள் ,

Kura Oncology, Inc. (KURA) Q1 2021 Earnings Call Transcript

Operator
Welcome to the quarter one 2021 Kura Oncology, Inc. Earnings Conference Call. My name is Jenny. I ll be your operator for today s call. [Operator Instructions] I will now turn the call over to Pete De Spain. You may begin.
Pete De Spain
Vice President, Investor Relations and Corporate Communications
Thank you, Jenny. Good afternoon, and welcome to Kura s Oncology s First Quarter 2021 Conference Call. Joining me on the call are Dr. Troy Wilson, our President and Chief Executive Officer; and Dr. Marc Grasso, our Chief Financial Officer and Chief Business Officer. Jim Basta, our Chief Legal Officer; Dr. Stephen Dale, our Chief Medical Officer, Pearson Flowers, our Chief Commercial Officer; and Kathy Ford, our Chief Operating Officer, are also with us and available to answer questions. Before I turn the call over to Dr. Wilson, I would like to remind you that today s call will include forward-looking statements based on current expectations. Such statements ....

United States , Reni John Benjamin , Tiago Felipe Fauth , Marc Grasso , Phil Nadu , Peter Lawson , Stephen Dale , Kathy Ford , Jim Basta , Wei Ji Chang , Philipm Nadeau Cowen , Troy Wilson , Tiago Fauth , Troy Edward Wilson , Joe Pantginis , Reni Benjamin , Jonathan Chang , Peter Richard Lawson Barclays Bank , Cleer Inc , Joseph Pantginis Hc Wainwright Co Analyst , University Of Michigan , Corporate Communications , Kura Oncology Inc , Company Analyst , Translational Research , Cohen Company ,

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (ABUS) - Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge

Intellia Therapeutics, Inc. (NASDAQ: NTLA) (before the market open)
Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) (before the market open)
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) (before the market open)
Insmed Incorporated (NASDAQ: INSM) (before the market open)
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) (before the market open)
Endo International plc (NASDAQ: ENDP) (before the market open)
Bio-Techne Corporation (NASDAQ: TECH) (before the market open)
Harvard Bioscience, Inc. (NASDAQ: HBIO) (before the market open)
Athenex, Inc. (NASDAQ: ATNX) (before the market open)
Zoetis Inc. (NYSE: ZTS) (before the market open)
Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (before the market open)
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) (before the market open) ....

United States , Eli Lilly , American Psychiatric Association , Atara Biotherapeutics Inc , Arthritis Advisory Committee , Coherus Biosciences Inc , Neovasc Inc , Elanco Animal Health Incorporated , Intellia Therapeutics Inc , Sangamo Therapeutics Inc , Nuvasive Inc , Axogen Inc , Celcuity Inc , Orasure Technologies Inc , Albireo Pharma Inc , Gel Technologies Ltd , World Vaccine Congress Washington , Novabay Pharmaceuticals Inc , Passage Bio Inc , Aquestive Therapeutics Inc , Diamedica Therapeutics Inc , Meridian Bioscience Inc , Catalent Inc , Lantheus Holdings Inc , Aeglea Biotherapeutics Inc , Athersys Inc ,

Kura Oncology Announces Publication of Tipifarnib Phase 2 Data in Journal of Clinical Oncology

Kura Oncology Announces Publication of Tipifarnib Phase 2 Data in Journal of Clinical Oncology
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

Roberth Uhl , Asia Pacific , Troy Wilson , Exchange Commission , Corporate Communications , Kura Oncology Inc , Canale Communications , Memorial Sloan Kettering Cancer Center , Neck Squamous Cell Carcinoma , Clinical Oncology , Chief Executive Officer , Breakthrough Therapy Designation , Fast Track , Sloan Kettering , Investor Relations , ஆசியா பெஸிஃபிக் , டிராய் வில்சன் , பரிமாற்றம் தரகு , பெருநிறுவன தகவல்தொடர்புகள் , குரா புற்றுநோயியல் இன்க் , கால்வாய் தகவல்தொடர்புகள் , நினைவகம் ஸ்லோன் கெட்டரிங் புற்றுநோய் மையம் , மருத்துவ புற்றுநோயியல் , தலைமை நிர்வாகி அதிகாரி , திருப்புமுனை சிகிச்சை பதவி , வேகமாக டிராக் ,

neck cancer

neck cancer
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Merck Co Inc , Nektar Therapeutics , Kura Oncology Inc , Neck Cancer Studytuesday , Therapy Tag For Tipifarnib In Head , Neck Cancerwednesday , Breakthrough Therapy , Therapeutics Secures , For New Study With , Pembrolizumab Combo In Head , மெர்க் இணை இன்க் , னெக்தார் சிகிச்சை , குரா புற்றுநோயியல் இன்க் , திருப்புமுனை சிகிச்சை , க்கு புதியது படிப்பு உடன் ,